Purchases and Sales Made in Q3 2024 in Immix Biopharma, Inc. (IMMX)
This table provides information about the institutional ownership of Immix Biopharma, Inc. (IMMX) during Q3 2024. The information is specifically focused on institutions that hold shares of Immix Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
100K+ 16.71% |
$149K - $245K
|
699K
$1.54M
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
83.9K+ 63057.89% |
$125K - $205K
|
84K
$185K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
25.9K+ 44.23% |
$38.5K - $63.3K
|
84.3K
$185K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.95K+ 5.6% |
$11.9K - $19.5K
|
150K
$330K
|
|
|
Nov 08, 2024
Q3 2024
|
Tocqueville Asset Management L.P.
New York, NY |
BUY
|
- |
5.5K+ 14.55% |
$8.2K - $13.5K
|
43.3K
$95.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
2.99K+ 94.86% |
$4.46K - $7.33K
|
6.15K
$13.5K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-876- 21.98% |
$1.31K - $2.15K
|
3.11K
$6.84K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-4.78K- 18.17% |
$7.12K - $11.7K
|
21.5K
$47.3K
|
|
|
Oct 22, 2024
Q3 2024
|
Private Advisor Group, LLC
|
SELL
|
- |
-30.9K- 47.33% |
$46K - $75.6K
|
34.3K
$75.5K
|
|
|
Nov 13, 2024
Q3 2024
|
Aigh Capital Management LLC
Baltimore, MD |
SELL
|
- |
-283K- 20.12% |
$422K - $693K
|
1.12M
$2.47M
|